{"id":"W4292731103","doi":"10.2337/dc22-0382","title":"Dapagliflozin and Prevention of Kidney Disease Among Patients With Type 2 Diabetes: Post Hoc Analyses From the DECLARE-TIMI 58 Trial","year":2022,"lang":"en","type":"article","venue":"Diabetes Care","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Janssen Pharmaceuticals; Janssen Research and Development; Merck Sharp and Dohme; St. Jude Medical; Genentech; Idorsia Pharmaceuticals; Duke Clinical Research Institute; Eisai; Hebrew University of Jerusalem; Daiichi-Sankyo; Deutsche Forschungsgemeinschaft; University of Liverpool; Bayer HealthCare; Zora Biosciences; Belvoir Media Group; HLS Therapeutics; GlaxoSmithKline; IFM Therapeutics; Allergan; AstraZeneca; Amarin Corporation; Regado Biosciences; Medicines Company; American Heart Association; Intarcia Therapeutics; Ironwood Pharmaceuticals, Incorporated; Regeneron Pharmaceuticals; Brigham and Women's Hospital; Boston VA Research Institute; Boston Scientific Corporation; Novo Nordisk; MyoKardia; Daiichi Sankyo Europe; Servier; Gilead Sciences; Bristol-Myers Squibb; Cleveland Clinic; CSL Behring; Eli Lilly and Company; Moderna; Pfizer; Amgen; Sanofi; Esperion Therapeutics; Alnylam Pharmaceuticals; U.S. Department of Veterans Affairs","keywords":"Medicine; Dapagliflozin; TIMI; Type 2 diabetes; Post-hoc analysis; Diabetes mellitus; Post hoc; Kidney disease; Internal medicine; Endocrinology; Myocardial infarction","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000879534,0.0002072792,0.0003608913,0.00009794845,0.0001743825,0.00003385987,0.000140472,0.00003029763,0.0003162622],"category_scores_gemma":[0.0001772614,0.0001375809,0.0001296732,0.0002996005,0.0001033586,0.0001116609,0.0002012102,0.0001152062,0.000005629238],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007744649,"about_ca_system_score_gemma":0.0001071058,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001972548,"about_ca_topic_score_gemma":0.00001069104,"domain_scores_codex":[0.9985595,0.0001325807,0.0002376664,0.000336944,0.0004690865,0.000264261],"domain_scores_gemma":[0.9988601,0.0001057036,0.0001651478,0.0004387622,0.0001728461,0.0002574985],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002628181,0.0003522934,0.9864278,0.000110964,0.0007468832,0.000002932649,0.0003991306,0.0000160348,0.00008482624,0.000007111762,0.003796526,0.005427275],"study_design_scores_gemma":[0.02448461,0.004072275,0.9622172,0.0002094381,0.002836266,7.822398e-9,0.001301057,0.00007238207,0.0003102791,0.00005278314,0.004231936,0.000211778],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9953421,0.001729037,6.904505e-7,0.0002466707,0.0002156363,0.001431502,0.0007640873,0.00004076309,0.0002295405],"genre_scores_gemma":[0.9929895,0.00002316459,0.00009587494,0.0008294506,0.00007368618,0.0002131131,0.005574781,0.00003210041,0.0001683194],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02421065,"threshold_uncertainty_score":0.5610386,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01387560533012188,"score_gpt":0.2528839134357027,"score_spread":0.2390083081055808,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}